13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-15, with 40 holding rows worth $307,379,517.
- Accession
- 0001493152-23-041364
- Filer
- CIK 1595855
- Filed
- 2023-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 41 entries on the cover page, a total value of $307,379,517 stated on the cover page (in dollars after the unit check, H1), rows summing to $307,379,517 with VALUE read as dollars as filed, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HARROW INC | 415858109 | COM | 3,795,000 | $54,534,150 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 4,146,138 | $42,166,223 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 6,468,000 | $20,309,520 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 1,890,000 | $15,800,400 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 653,000 | $14,970,025 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 1,205,000 | $14,086,450 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 360,400 | $11,489,552 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 439,000 | $11,418,390 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 370,000 | $11,003,800 | dollars as filed | |
| ETON PHARMACEUTICALS INC | 29772L108 | COMMON STOCK | 2,430,270 | $10,134,226 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 311,500 | $8,404,270 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 1,209,380 | $8,127,034 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 750,000 | $6,000,000 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 875,405 | $5,016,071 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 500,000 | $4,815,000 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 584,000 | $4,701,200 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 90,000 | $4,588,200 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 2,692,594 | $4,496,632 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 320,000 | $4,483,200 | dollars as filed | |
| GERON CORP | 374163103 | COM | 1,915,000 | $4,059,800 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 4,754,200 | $3,959,298 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 308,500 | $3,927,205 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 274,500 | $3,867,705 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,705,900 | $3,718,862 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 570,700 | $3,618,238 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 848,500 | $3,351,575 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 441,896 | $3,115,367 | dollars as filed | |
| GOSSAMER BIO INC | 38341PAA0 | NOTE 5.000% 6/0 | 8,000,000 | $3,098,704 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 455,573 | $3,038,295 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 610,000 | $2,775,500 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 893,000 | $2,223,570 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 261,000 | $2,179,350 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 1,118,900 | $2,114,721 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 211,400 | $1,718,682 | dollars as filed | |
| PRECIGEN INC | 74017N105 | COM | 928,500 | $1,318,470 | dollars as filed | |
| TRACON PHARMACEUTICALS INC | 89237H209 | COM NEW | 4,764,508 | $848,082 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 390,000 | $725,400 | dollars as filed | |
| FORTRESS BIOTECH INC | 34960Q109 | COM | 2,000,000 | $580,600 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 425,000 | $505,750 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 30,000 | $90,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-23-041364 | this filing | 2023-11-15 | acceptance time not in the bulk data set |